Atherectomy Devices Market Positive long-term growth outlook by Leading Players: Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., Boston Scientific Corporation, Avinger, Inc

Atherectomy devices are the medical devices, which are used for removing atherosclerosis from blood vessels within the body. Atherectomy devices are alternative to angioplasty and widely used to treat narrowing in arteries caused by peripheral artery disease. There are four types of atherectomy namely: Directional atherectomy, Rotational atherectomy, Laser atherectomy, and Orbital atherectomy.

Increasing prevalence of cardiovascular diseases (CVD’s) is expected to drive growth of atherectomy devices market. According to article published in the European Heart Network (EHN) in 2017, CVD causes around 3.9 million deaths in Europe annually and over 1.8 million deaths in the European Union, which accounts for about 45% of all deaths in Europe and 37% of all deaths in the EU. Furthermore launches of innovative products and frequent approval of these devices from regulatory bodies is expected to drive growth of the atherectomy devices market. In 2018, Avinger Inc., received CE Marking approval for next-generation Pantheris Lumivascular atherectomy system, an image-guided atherectomy device for the treatment of Peripheral artery disease. Increasing adoption of novel product is expected to fuel growth of the global atherectomy devices market.

Request for a sample of this research report @ https://www.coherentmarketinsights.com/insight/request-sample/1325

In 2015, Spectranetics Corporation received FDA approval for Turbo-Power Laser Atherectomy Catheter, which indicated atherectomy device for treatment of in-stent restenosis. In 2017, Avinger, Inc. received Conformité Européenne (CE) marking approval for next generation Pantheris Lumivascular atherectomy system. In 2017, Ra Medical Systems launched DABRA Atherectomy System in Northern Europe. In 2015, Medtronic Plc. launched its HawkOne directional atherectomy system for the treatment of peripheral arterial disease. Multiple approval and then launch of these innovative devices is expected to support the growth of global atherectomy devices Market.

Browse 36 Market Data Tables and 40 Figures spread through 186 Pages and in-depth TOC on Vascular Closure Device by Device Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, and Laser Atherectomy Devices), By Application (Cardiovascular, Neurovascular and Peripheral Vascular), By End User (Hospitals, Ambulatory Surgical Centers, and Medical Institutes) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025

Furthermore, the market has witnessed multiple mergers and acquisitions is recent years, which has helped leading companies to its atherectomy device portfolio and hence, strengthen position in atherectomy device market. In 2014, Boston Scientific Corporation acquired Bayer AG interventional business. This acquisition includes AngioJet Thrombectomy System, Fetch 2 Aspiration Catheter, and JetStream Atherectomy System. The JetStream Atherectomy System is used to remove plaque and thrombus from diseased arteries. In 2014, Medtronic plc acquired Covidien plc in order to expand portfolio of atherectomy device. After this acquisition, Medtronic plc became the sole owner of leading atherectomy devices such as HawkOne, TurboHawk, and may others.

Major players operating in the atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., Boston Scientific Corporation, Avinger, Inc, C. R. Bard, Inc, Cardinal Health, Inc., Minnetronix, Inc., Straub Medical AG, and Biotronik

For More Information On This Report, Please Visit @ https://www.coherentmarketinsights.com/market-insight/atherectomy-devices-market-1325

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.